| References: |
Partial agonist of α7 nicotinic acetylcholine receptors (nAChRs); also a weak α4β2 and 5-HT3 antagonist at micromolar concentrations. Exhibits improved sensory inhibition in DBA/2 mice following both acute and chronic administration. Also shown to improve memory in several animal models; facilitates hippocampal long-term potentiation. For the detailed information of GTS 21 2HCl(DMXBA), the solubility of GTS 21 2HCl(DMXBA) in water, the solubility of GTS 21 2HCl(DMXBA) in DMSO, the solubility of GTS 21 2HCl(DMXBA) in PBS buffer, the animal experiment (test) of GTS 21 2HCl(DMXBA), the cell expriment (test) of GTS 21 2HCl(DMXBA), the in vivo, in vitro and clinical trial test of GTS 21 2HCl(DMXBA), the EC50, IC50,and affinity,of GTS 21 2HCl(DMXBA), For the detailed information of GTS 21 2HCl(DMXBA), the solubility of GTS 21 2HCl(DMXBA) in water, the solubility of GTS 21 2HCl(DMXBA) in DMSO, the solubility of GTS 21 2HCl(DMXBA) in PBS buffer, the animal experiment (test) of GTS 21 2HCl(DMXBA), the cell expriment (test) of GTS 21 2HCl(DMXBA), the in vivo, in vitro and clinical trial test of GTS 21 2HCl(DMXBA), the EC50, IC50,and affinity,of GTS 21 2HCl(DMXBA), Please contact DC Chemicals. |
